Dr. Richard Grant Morshedi, MD

Dr. Morshedi practices at Little Rock Eye Clinic in Little Rock, Arkansas.

Dr. Morshedi's NPI, 1295989697, was assigned on November 11, 2008. Dr. Morshedi graduated from University of Arkansas College of Medicine in 2008. Dr. Morshedi holds Arkansas license E-7996.

Dr. Morshedi's primary practice is Little Rock Eye Clinic, at 201 Executive Ct, Little Rock, AR 72205 in Pulaski County. The practice phone is (501) 224-5658.

Dr. Morshedi's primary practice is Little Rock Eye Clinic in Little Rock, Arkansas. Dr. Morshedi is also affiliated with Baptist Health Medical Center-Little Rock. The medical group on file is UAMS - University of Arkansas for Medical Sciences. Dmand AI also links Dr. Morshedi to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Morshedi practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Morshedi's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Morshedi is licensed in Arkansas.

CMS data shows 3,994 Medicare services from Dr. Morshedi across 19 procedure codes in 2024, for 974 Medicare patients. Medicare paid $265,854 for them.

CMS counts 974 Medicare patients who saw Dr. Morshedi in 2024. The largest group is 75 to 84, with 419 patients. 75% of them have high blood pressure, and 70% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.01, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Morshedi's median patient age at 73, with 53% women.

In 2024, Dr. Morshedi wrote 8,302 Medicare Part D claims for 1,092 patients. 73% of them were for generic drugs. CMS names the drug for 8,219 of them, across 29 drugs with 11 or more claims each, at $404,257 in total drug cost. In 2023, CMS named 7,769 claims across 27 drugs.

Dr. Morshedi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 232 procedures of cataract surgery by Dr. Morshedi, more than 86% of the clinicians it reports for that procedure.

Dmand AI links 8 papers to Dr. Morshedi, published from 2012 to 2020. The most frequent topics are Intraocular Pressure, Glaucoma and Ocular Hypertension. Dr. Morshedi has published most often in J Glaucoma. Dr. Morshedi's most frequent co-authors are Daniel Bettis, MD, Joshua Spicer Hardin, MD and Aaron M. Ricca, MD.

CMS Open Payments shows 49 general payments to Dr. Morshedi from 10 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 60% of the total. Allergan Inc. paid the most, $1,127.

Dr. Morshedi graduated from University of Arkansas College of Medicine in 2008.